Performing a standardized 60-second hair count appears to be a reliable method
for the assessment of hair shedding, according to a new report.
"Currently, there is no widely accepted or standard method for assessing the
number of hairs shed daily," according to background information in the article.
The widely held belief that it is normal to shed 100 hairs per day is based on
the assumption that the average scalp contains 100,000 hairs, 10 percent of
which are in the telogen (resting) phase. Although this idea is prevalent, it
has not been scientifically validated and does not indicate whether shedding
remains constant with age or if it is similar between men and women.
Carina A. Wasko, M.D., of Baylor College of Medicine, Houston, and colleagues
studied hair loss in 60 healthy men (half age 20 to 40 and half age 41 to 60)
without evidence of alopecia (baldness). All participants were given identical
combs and instructions to wash hair with the same brand of shampoo for three
consecutive mornings. On the fourth day, they were asked to comb hair forward
for 60 seconds over a towel or pillowcase of contrasting color before
shampooing. The men combed their hair this way and then counted hairs shed for
three consecutive days. This procedure was repeated in eligible participants six
months later.
Participants age 20 through 40 shed 0 to 78 hairs, with an average loss of
10.2 hairs per 60-second test. Men age 41 to 60 shed 0 to 43 hairs, with an
average loss of 10.3 hairs per 60-second test. Results were consistent on
consecutive days for all participants. "When repeated six months later in both
age groups, the hair counts did not change much. The hair counts were repeated
and verified by a trained investigator, with results similar to those of subject
hair counts," the authors write.
"In summary, the 60-second hair count is a simple, practical and objective
tool for monitoring conditions associated with hair shedding," the authors
conclude. "Low intrapatient variability demonstrates that dependable results
over an extended period of time are obtainable. The similarity between
investigator and subject hair counts indicates that patients can reliably count
hairs.
"Studies of the 60-second hair count in normal women and in the setting of
hair disease still need to be performed."
Co-author Dr. Miller is a consultant for and has received honoraria from
Pfizer Inc. This study was supported by a study grant from Merck.